Clinical Trial Update: NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NanaBis, an oro-buccal d9-THC & CBD medicine for cancer-related bone pain; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain
• Cancer-related Bone Pain
• Cancer-related Pain

Drugs mentioned

• NanaBis (delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD))

Snippet

Sponsor: Medlab Clinical | Conditions: Cancer Related Pain | Phase 3 | Status: UNKNOWN